The GLP-1 agonists drug pipeline analysis explores innovative therapies aimed at managing diabetes and obesity, driven by strong clinical demand and advancements in metabolic treatments. https://www.expertmarketresearch.com/clinical-trials/glp-1-agonists-drug-pipeline-insight